Dr. Bruce Cohen, MD

Neurological Surgery Chicago, IL Male
NPI: 1174553580
Total Payments
$250,373
2024 Payments
$8,837
Companies
16
Transactions
126
Medicare Patients
1,396
Medicare Billing
$2.8M

Payment Breakdown by Category

Consulting$222,193 (88.7%)
Other$10,554 (4.2%)
Education$7,116 (2.8%)
Travel$5,644 (2.3%)
Food & Beverage$2,684 (1.1%)
Research$2,184 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $222,193 49 88.7%
Education $7,116 9 2.8%
Travel and Lodging $5,644 24 2.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,554 1 2.2%
Honoraria $5,000 1 2.0%
Food and Beverage $2,684 40 1.1%
Unspecified $2,184 2 0.9%

Payments by Type

General
$248,189
124 transactions
Research
$2,184
2 transactions

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $70,980 14 $0 (2023)
SANOFI US SERVICES INC. $66,066 14 $0 (2022)
EMD Serono, Inc. $25,391 24 $0 (2022)
Biogen, Inc. $15,027 16 $0 (2020)
Mylan Specialty L.P. $14,619 3 $0 (2023)
Mylan Pharmaceuticals Inc. $10,120 1 $0 (2022)
SANOFI-AVENTIS U.S. LLC $9,900 9 $0 (2024)
Celgene Corporation $9,847 6 $0 (2020)
Novartis Pharmaceuticals Corporation $8,649 11 $0 (2024)
Mylan Institutional Inc. $6,930 8 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $8,837 10 SANOFI-AVENTIS U.S. LLC ($8,700)
2023 $12,704 6 GENZYME CORPORATION ($6,962)
2022 $74,843 14 GENZYME CORPORATION ($41,496)
2021 $78,890 18 SANOFI US SERVICES INC. ($40,677)
2020 $16,755 8 Biogen, Inc. ($8,410)
2019 $23,691 34 EMD Serono, Inc. ($10,596)
2018 $28,428 27 EMD Serono, Inc. ($14,773)
2017 $6,226 9 Novartis Pharmaceuticals Corporation ($6,226)

All Payment Transactions

126 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/12/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $29.44 General
Category: Neurology
11/11/2024 UCB, Inc. — Food and Beverage In-kind items and services $107.31 General
09/11/2024 SANOFI-AVENTIS U.S. LLC — Consulting Fee Cash or cash equivalent $3,300.00 General
09/11/2024 SANOFI-AVENTIS U.S. LLC — Consulting Fee Cash or cash equivalent $450.00 General
08/14/2024 SANOFI-AVENTIS U.S. LLC — Consulting Fee Cash or cash equivalent $1,950.00 General
07/11/2024 SANOFI-AVENTIS U.S. LLC — Consulting Fee Cash or cash equivalent $900.00 General
06/12/2024 SANOFI-AVENTIS U.S. LLC — Consulting Fee Cash or cash equivalent $450.00 General
05/15/2024 SANOFI-AVENTIS U.S. LLC — Consulting Fee Cash or cash equivalent $750.00 General
04/05/2024 SANOFI-AVENTIS U.S. LLC — Consulting Fee Cash or cash equivalent $750.00 General
03/07/2024 SANOFI-AVENTIS U.S. LLC — Consulting Fee Cash or cash equivalent $150.00 General
12/13/2023 SANOFI-AVENTIS U.S. LLC — Consulting Fee Cash or cash equivalent $1,200.00 General
12/05/2023 Mylan Specialty L.P. — Consulting Fee Cash or cash equivalent $4,464.50 General
09/09/2023 Mylan Specialty L.P. — Travel and Lodging In-kind items and services $34.30 General
05/31/2023 Genentech USA, Inc. Enspryng (Biological), Ocrevus Food and Beverage In-kind items and services $43.72 General
Category: Immunology
02/09/2023 GENZYME CORPORATION — Consulting Fee Cash or cash equivalent $273.00 General
01/12/2023 GENZYME CORPORATION — Consulting Fee Cash or cash equivalent $6,688.50 General
12/15/2022 GENZYME CORPORATION — Consulting Fee Cash or cash equivalent $2,184.00 General
11/15/2022 GENZYME CORPORATION — Consulting Fee Cash or cash equivalent $1,228.50 General
10/13/2022 GENZYME CORPORATION — Consulting Fee Cash or cash equivalent $409.50 General
09/14/2022 GENZYME CORPORATION — Consulting Fee Cash or cash equivalent $2,320.50 General
08/16/2022 GENZYME CORPORATION — Consulting Fee Cash or cash equivalent $4,368.00 General
07/15/2022 GENZYME CORPORATION — Consulting Fee Cash or cash equivalent $7,234.50 General
06/15/2022 GENZYME CORPORATION — Consulting Fee Cash or cash equivalent $7,507.50 General
05/13/2022 GENZYME CORPORATION — Consulting Fee Cash or cash equivalent $8,599.50 General
04/21/2022 EMD Serono, Inc. — Food and Beverage Cash or cash equivalent $22.12 General
123…6»

Research Studies & Clinical Trials

Study Name Company Amount Records
A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis SANOFI US SERVICES INC. $2,184 2

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 313 11,596 $2.6M $532,659
2022 12 393 25,627 $3.4M $779,523
2021 10 352 35,333 $3.9M $937,882
2020 11 338 25,185 $2.4M $591,168
Total Patients
1,396
Total Services
97,741
Medicare Billing
$2.8M
Procedure Codes
42

All Medicare Procedures & Services

42 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J2350 Injection, ocrelizumab, 1 mg Office 2023 17 11,100 $2.4M $499,821 20.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 111 170 $54,910 $15,379 28.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 45 54 $23,436 $7,218 30.8%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 26 36 $33,840 $3,927 11.6%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 26 63 $25,830 $3,434 13.3%
96415 Administration of chemotherapy into vein, each additional hour Office 2023 23 58 $12,470 $1,390 11.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 11 12 $2,628 $692.10 26.3%
96375 Injection of additional new drug or substance into vein Office 2023 27 40 $5,720 $524.04 9.2%
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg Office 2023 27 63 $630.00 $274.48 43.6%
J2350 Injection, ocrelizumab, 1 mg Office 2022 20 11,700 $2.5M $535,313 21.1%
J2323 Injection, natalizumab, 1 mg Office 2022 13 13,200 $620,400 $202,141 32.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 115 169 $54,587 $15,313 28.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 59 76 $32,984 $10,122 30.7%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2022 23 80 $32,800 $4,631 14.1%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2022 31 36 $33,840 $4,215 12.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 15 15 $9,375 $2,453 26.2%
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour Office 2022 12 109 $14,061 $1,974 14.0%
96415 Administration of chemotherapy into vein, each additional hour Office 2022 29 77 $16,555 $1,892 11.4%
96375 Injection of additional new drug or substance into vein Office 2022 32 45 $6,435 $598.97 9.3%
96361 Infusion into a vein for hydration, each additional hour Office 2022 13 48 $4,800 $537.85 11.2%
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg Office 2022 31 72 $720.00 $330.28 45.9%
J2350 Injection, ocrelizumab, 1 mg Office 2021 20 12,600 $2.6M $541,952 20.8%
J2323 Injection, natalizumab, 1 mg Office 2021 14 21,900 $1.0M $350,876 34.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 101 162 $52,326 $14,526 27.8%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 49 66 $28,644 $9,181 32.1%
12»

About Dr. Bruce Cohen, MD

Dr. Bruce Cohen, MD is a Neurological Surgery healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174553580.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Cohen, MD has received a total of $250,373 in payments from pharmaceutical and medical device companies, with $8,837 received in 2024. These payments were reported across 126 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($222,193).

As a Medicare-enrolled provider, Cohen has provided services to 1,396 Medicare beneficiaries, totaling 97,741 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.

Practice Information

  • Specialty Neurological Surgery
  • Other Specialties Neurology
  • Location Chicago, IL
  • Active Since 07/03/2006
  • Last Updated 02/16/2022
  • Taxonomy Code 207T00000X
  • Entity Type Individual
  • NPI Number 1174553580

Products in Payments

  • TECFIDERA (Drug) $14,844
  • YUPELRI (Drug) $10,120
  • Mavenclad (Biological) $8,736
  • Ozanimod (Drug) $7,987
  • Glatiramer Acetate (Drug) $6,930
  • Rebif (Biological) $6,840
  • GILENYA (Drug) $6,226
  • UPLIZNA (Drug) $5,170
  • OCREVUS (Biological) $4,900
  • MAYZENT (Drug) $2,394
  • ZEPOSIA (Drug) $1,860
  • Non-Covered Product (Drug) $1,800
  • Rituxan (Biological) $266.00
  • Stimulan (Device) $49.69
  • Enspryng (Biological) $43.72
  • KESIMPTA (Drug) $29.44

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurological Surgery Doctors in Chicago

Tyler Koski, Md, MD

Neurological Surgery — Payments: $2.7M

Neurological Surgery $2.7M

Vincent Traynelis, Md, MD

Neurological Surgery — Payments: $2.2M

Neurological Surgery $2.2M

Dr. Richard Fessler, Md, MD

Neurological Surgery — Payments: $1.8M

Neurological Surgery $1.8M

Dr. Sergey Neckrysh, Md, MD

Neurological Surgery — Payments: $1.4M

Neurological Surgery $1.4M

Fady Charbel, M.d, M.D

Neurological Surgery — Payments: $618,346

Neurological Surgery $618,346

John O'toole, M.d, M.D

Neurological Surgery — Payments: $589,465

Neurological Surgery $589,465